carbamates has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaunders, JJ | 1 |
| Kaufmann, GR | 1 |
| Cunningham, PH | 1 |
| Smith, D | 1 |
| Grey, P | 1 |
| Suzuki, K | 1 |
| Carr, A | 1 |
| Goh, LE | 1 |
| Cooper, DA | 1 |
1 other study available for carbamates and EBV Infections
| Article | Year |
|---|---|
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleos | 2001 |